Miriam Haak, Director Business Development at Miltenyi Biotec GmbH, is responsible for the evaluation and establishment of partnership programs in the context of Miltenyi Biotec’s lentiviral vector and cell manufacturing services. She worked as an immunologist at the Max-Planck-Institute for Immunology in Freiburg, did her PhD in molecular oncology at the University of Muenster and worked at the PT-DLR in managing and developing funding priorities for the Federal Ministry of Education and Research.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.